Page last updated: 2024-11-05

viloxazine and Obesity

viloxazine has been researched along with Obesity in 1 studies

Viloxazine: A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirby, MJ1
Pleece, SA1
Redfern, PH1

Other Studies

1 other study available for viloxazine and Obesity

ArticleYear
The effect of viloxazine hydrochloride (Vivalan) on food intake and obesity in the rat [proceedings].
    The Journal of pharmacy and pharmacology, 1978, Volume: 30 Suppl

    Topics: Animals; Body Weight; Feeding Behavior; Female; Morpholines; Obesity; Rats; Viloxazine

1978